Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
Liver resection is the only curative treatment for patients with colorectal liver metastases (CLMs). Neoadjuvant chemotherapy can improve resectability but has a potential harmful effect on the nontumorous liver. Patients with chemotherapy-induced hepatic injury undergoing liver surgery have higher...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2009/457975 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832564146169708544 |
---|---|
author | Maartje A. J. van den Broek Steven W. M. Olde Damink Ann Driessen Cornelis H. C. Dejong Marc H. A. Bemelmans |
author_facet | Maartje A. J. van den Broek Steven W. M. Olde Damink Ann Driessen Cornelis H. C. Dejong Marc H. A. Bemelmans |
author_sort | Maartje A. J. van den Broek |
collection | DOAJ |
description | Liver resection is the only curative treatment for patients with colorectal liver metastases (CLMs). Neoadjuvant chemotherapy can improve resectability but has a potential harmful effect on the nontumorous liver. Patients with chemotherapy-induced hepatic injury undergoing liver surgery have higher risks of post-resectional morbidity. We present two cases of patients without pre-existent liver disease treated with oxaliplatin-based chemotherapy followed by surgical resection of their CLMs. Their intra-operative liver specimen showed morphologic abnormalities characteristic of nodular regenerative hyperplasia (NRH). NRH led to portal hypertension in both patients that resulted in deleterious post-resectional complications and death of one patient. Interestingly, the other patient underwent two repeat nonanatomic liver resections because of recurrent CLMs. The intra-operative liver specimen still showed signs of NRH and sinusoidal congestion, but the post-resectional courses were uneventful. Nevertheless, caution is recommended in patients with suspected NRH. Careful volumetric analysis should guide the operative strategy. When future remnant liver volume is regarded insufficient, portal vein embolization or restrictive surgery should be considered. |
format | Article |
id | doaj-art-c8bf6f45b90e43f1b83a6350aecf75c2 |
institution | Kabale University |
issn | 1687-9627 1687-9635 |
language | English |
publishDate | 2009-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Medicine |
spelling | doaj-art-c8bf6f45b90e43f1b83a6350aecf75c22025-02-03T01:11:47ZengWileyCase Reports in Medicine1687-96271687-96352009-01-01200910.1155/2009/457975457975Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver MetastasesMaartje A. J. van den Broek0Steven W. M. Olde Damink1Ann Driessen2Cornelis H. C. Dejong3Marc H. A. Bemelmans4Department of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Pathology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsLiver resection is the only curative treatment for patients with colorectal liver metastases (CLMs). Neoadjuvant chemotherapy can improve resectability but has a potential harmful effect on the nontumorous liver. Patients with chemotherapy-induced hepatic injury undergoing liver surgery have higher risks of post-resectional morbidity. We present two cases of patients without pre-existent liver disease treated with oxaliplatin-based chemotherapy followed by surgical resection of their CLMs. Their intra-operative liver specimen showed morphologic abnormalities characteristic of nodular regenerative hyperplasia (NRH). NRH led to portal hypertension in both patients that resulted in deleterious post-resectional complications and death of one patient. Interestingly, the other patient underwent two repeat nonanatomic liver resections because of recurrent CLMs. The intra-operative liver specimen still showed signs of NRH and sinusoidal congestion, but the post-resectional courses were uneventful. Nevertheless, caution is recommended in patients with suspected NRH. Careful volumetric analysis should guide the operative strategy. When future remnant liver volume is regarded insufficient, portal vein embolization or restrictive surgery should be considered.http://dx.doi.org/10.1155/2009/457975 |
spellingShingle | Maartje A. J. van den Broek Steven W. M. Olde Damink Ann Driessen Cornelis H. C. Dejong Marc H. A. Bemelmans Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases Case Reports in Medicine |
title | Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases |
title_full | Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases |
title_fullStr | Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases |
title_full_unstemmed | Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases |
title_short | Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases |
title_sort | nodular regenerative hyperplasia secondary to neoadjuvant chemotherapy for colorectal liver metastases |
url | http://dx.doi.org/10.1155/2009/457975 |
work_keys_str_mv | AT maartjeajvandenbroek nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases AT stevenwmoldedamink nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases AT anndriessen nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases AT cornelishcdejong nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases AT marchabemelmans nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases |